Selective heparanase localization in malignant melanoma

  • Authors:
    • Brian P. Murry
    • Andrea Greiter-Wilke
    • Daniel P. Paulsen
    • Kim M. Hiatt
    • Carlo Alberto Beltrami
    • Dario Marchetti
  • View Affiliations

  • Published online on: February 1, 2005     https://doi.org/10.3892/ijo.26.2.345
  • Pages: 345-352
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Heparanase (HPSE-1) is an endo-β-D-glucuronidase that cleaves heparan sulfate proteoglycans (HSPG), and its expression has been associated with increased growth, metastasis, and angiogenesis of tumors. Since metastatic melanoma cells express high levels of HSPG and because melanoma tumors grow highly vascularized, we analyzed melanoma tissue specimens for HPSE-1 expression from experimental animals as well as from patients. Laser capture microdissection microscopy was used to extract melanoma cell populations and to isolate them from adjacent tissue. In experimental animals, a 29-fold upregulation of HPSE-1 expression was detected by real-time PCR in metastatic melanoma compared to normal lung tissue. Additionally, immunohistochemistry (IHC) revealed selective HPSE-1 staining in human metastatic melanoma when compared to primary melanoma tumors from the same patient. IHC also showed a marked staining for the enzyme around blood vessels and in vascularized regions. Our results provide evidence demonstrating that HPSE-1 likely plays important roles in regulating the in vivo growth and progression of melanoma. These results further emphasize the importance that therapies designed to block HPSE-1 activity may aid in controlling this type of cancer.

Related Articles

Journal Cover

February 2005
Volume 26 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Murry BP, Greiter-Wilke A, Paulsen DP, Hiatt KM, Beltrami CA and Marchetti D: Selective heparanase localization in malignant melanoma. Int J Oncol 26: 345-352, 2005
APA
Murry, B.P., Greiter-Wilke, A., Paulsen, D.P., Hiatt, K.M., Beltrami, C.A., & Marchetti, D. (2005). Selective heparanase localization in malignant melanoma. International Journal of Oncology, 26, 345-352. https://doi.org/10.3892/ijo.26.2.345
MLA
Murry, B. P., Greiter-Wilke, A., Paulsen, D. P., Hiatt, K. M., Beltrami, C. A., Marchetti, D."Selective heparanase localization in malignant melanoma". International Journal of Oncology 26.2 (2005): 345-352.
Chicago
Murry, B. P., Greiter-Wilke, A., Paulsen, D. P., Hiatt, K. M., Beltrami, C. A., Marchetti, D."Selective heparanase localization in malignant melanoma". International Journal of Oncology 26, no. 2 (2005): 345-352. https://doi.org/10.3892/ijo.26.2.345